Published April 27, 2018
| Version v1
Dataset
Open
The process of HDAC11 Assay Development: time-course study follow-up
Description
The time of incubation and conc. of the developer to be used are important parameters during HDAC11 assay optimization and thus, have been considered here.
Notes
The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files
27april2018-HDAC11 assay deve process-time course followup.pdf
Files
(174.5 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:c744051da19144a97749af66307162e2
|
174.5 kB | Preview Download |